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THE IMPORTANCE OF EXPOSOME IN PRECISION 
MEDICINE
Exposome refers to the set of external expo-
sures that affect an individual’s health from 
conception to death.1 This term includes all 
non- genetic risk factors which, interacting 
with the genetic endowment (genome), 
produce a state of health or disease 
(phenome). Considering these non- genetic 
data in precision medicine contributes to 
improving clinical decision making and 
biomedical research. It is still too frequent 
to find in the literature the description of 
research projects on certain diseases that 
only refer to the study of the genotype and 
the phenotype (https://www. icpermed. eu/ 
en/ icpermed- medicine. php). The same can 
be observed in database resources (https://
www. ncbi. nlm. nih. gov/ gap/). This indicates 
that either the exposome is neglected or the 
phenome is mistakenly considered to include 
the exposome (eg, smoking).
INTRODUCING THE CONCEPT OF EXPOTYPE
There is a scarcity of accepted standards to 
represent human exposure data. Therefore, 
representing individuals’ exposome data 
constitutes a challenge for biomedical infor-
matics, considering that it represents a source 
of big data that changes throughout time 
and space.2 To overcome this, the concept of 
expotype emerges as a fundamental term to 
facilitate a holistic approach to health.
Introducing the concept of expotype3 is a 
non- trivial issue, and so it is presented here by 
analogy with the terms genotype and phenotype. 
As the genome represents the complete DNA 
of a human organism, including all its genes, 
the term genotype refers to the genetic infor-
mation of one specific individual. Likewise, 
the concept of phenome represents all those 
features presented by a human organism, and 
the phenotype is defined as the structural 
and/or functional characteristics that can be 
observed about an individual, produced by 
the interaction between its genotype and its 
context. Finally, by analogy, the expotype would 
represent a specific set of exposures accumulated by 
an individual during a certain time/space window. 
In this sense, to understand how diseases 
are developed, it is mandatory to assess how 
the environmental risk factors (expotypes) 
interact with the genomic information of an 
individual (genotype), generating specific 
phenotypes.4 Collecting standardised data 
about individual genotypes, expotypes and 
phenotypes in research repositories offers the 
possibility of conducting integrative studies 
about the pathophysiology of complex 
diseases.
DESCRIPTION OF A COVID-19 EXPOTYPE
Multiple knowledge domains need to be inte-
grated to efficiently address current health 
challenges, such as the COVID-19 pandemic. 
SARS- CoV-2 has put great pressure on health 
systems, and it is an appropriate example of 
how external exposure plays a key role in 
affecting human health.
Building a COVID-19 expotype requires, 
besides the virus biology, considering all 
those factors related to its transmission and 
development, gathering individual data for 
health and research purposes. In general, 
environmental factors such as temperature 
and humidity play a key role in viral trans-
mission. Recent studies show that ecological 
factors (policy, health behaviours, physical 
environment and clinical care) are associated 
with COVID-19 case fatality rate.5 Further-
more, exposure to ultraviolet radiation 
favours the synthesis of vitamin D in the body, 
which plays an important role in the immune 
defence against viral and bacterial infections.6 
Additionally, a relevant correlation has been 
found between exposure to particulate matter 
(pollution) and COVID-19 death rates.7 On 
the one hand, pollution actively contrib-
utes to comorbidity, worsening the health of 
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fighting the virus. On the other hand, particulate matter 
may also be a possible virus carrier. Other environmental 
factors such as noise pollution and tobacco use have also 
been related to COVID-19.
SARS- CoV-2 effects are also related to social, cultural 
and behavioural factors. Measuring time spent by indi-
viduals outdoors and indoors is essential, given that most 
of the infections are related to extended human contact 
periods, mostly occurring in locations such as restaurants 
or gyms. Safety measures such as using masks or main-
taining social distance are also behavioural risk factors to 
be analysed in conjunction with the expotype data.
Individuals with obesity show greater likelihood of 
requiring special care and increased risk of death.8 More-
over, research has shown how food consumption influ-
ences brain neurotransmitter systems, affecting mood. 
Bidirectionally, mood can also influence food choices, 
leading to repetitive cycles of overeating, weight gain and 
depression. Hence, data related to eating habits also form 
part of COVID-19’s expotype structure,9 whereas psycho-
logical status would be part of the phenotype.
REPRESENTING EXPOTYPES WITH THE ISO-EN13606 MODEL 
(ARCHETYPES)
Today, digital health methods allow us to track individual 
exposure data. However, a standard model to process 
these data is still lacking. We present here a mechanism 
for data representation based on the concept of expo-
type, meaning specific exposures of an individual during 
a certain time/space window, and its representation using 
archetypes, based on the CEN/ISO- EN13606 data model 
international standard.10 Such standard data models will 
allow formalising and managing knowledge as it evolves, 
easily adapting it to new research and development needs.
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